Michael DiVecchia
Director de Operaciones en Elicio Therapeutics, Inc. (Old) .
Perfil
Michael DiVecchia is currently working as the Vice President of Operations & Program Management at Elicio Therapeutics, Inc. (United States).
Previously, he held the position of Senior VP of Operations & Human Resources at Elicio Therapeutics, Inc. from 2022 to 2024.
He completed his undergraduate degree at Syracuse University.
Cargos activos de Michael DiVecchia
| Empresas | Cargo | Inicio |
|---|---|---|
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Director de Operaciones | - |
Antiguos cargos conocidos de Michael DiVecchia.
| Empresas | Cargo | Fin |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Director de Operaciones | 01/01/2024 |
Formación de Michael DiVecchia.
| Syracuse University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael DiVecchia
